Serum creatinine elevation after switch to dolutegravir in a human immunodeficiency virus-positive kidney transplant recipient.

about

Serum creatinine elevation after switch to dolutegravir in a human immunodeficiency virus-positive kidney transplant recipient.

Item

http://www.wikidata.org/entity/Q40682190

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Serum creatinine elevation aft ...... e kidney transplant recipient.

@en

type

Item

label

Serum creatinine elevation aft ...... e kidney transplant recipient.

@en

prefLabel

Serum creatinine elevation aft ...... e kidney transplant recipient.

@en

P1476

Serum creatinine elevation aft ...... e kidney transplant recipient.

@en

P2093

A M Doyle

http://www.w3.org/2001/XMLSchema#string

D H Lee

http://www.w3.org/2001/XMLSchema#string

G E Malat

http://www.w3.org/2001/XMLSchema#string

K Ranganna

http://www.w3.org/2001/XMLSchema#string

M N Harhay

http://www.w3.org/2001/XMLSchema#string

T E Bias

http://www.w3.org/2001/XMLSchema#string

P2860

Transport of lamivudine [(-)-beta-L-2',3'-dideoxy-3'-thiacytidine] and high-affinity interaction of nucleoside reverse transcriptase inhibitors with human organic cation transporters 1, 2, and 3

Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat

Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial.

A National Study of Outcomes among HIV-Infected Kidney Transplant Recipients

A phase 1 study to evaluate the effect of dolutegravir on renal function via measurement of iohexol and para-aminohippurate clearance in healthy subjects.

Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study

Challenges and Clinical Decision-Making in HIV-to-HIV Transplantation: Insights From the HIV Literature.

Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection.

Center-Level Experience and Kidney Transplant Outcomes in HIV-Infected Recipients.

Once-daily dolutegravir is superior to once-daily darunavir/ritonavir in treatment-naïve HIV-1-positive individuals: 96 week results from FLAMINGO

P304

625-627

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TID.12545

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27159656

http://www.w3.org/2001/XMLSchema#string

P932

5525135

http://www.w3.org/2001/XMLSchema#string